Funding will be used to establish the clinical utility of OneMap™, a proprietary artificial intelligence (AI) driven single cell transcriptomic oncology platform, to guide treatment decisions, patient ...

At last count, the stock was trading 5.21 per cent higher at Rs 478.90. Despite the day's gains, the stock remains down 19 per cent on a year-to-date (YTD) basis.